Table 1.
Study population characteristics for CAH and control youth
| CAH (n = 27) | Controls (n = 35) | Group difference, p | |
|---|---|---|---|
| Age, years | 12.6±3.4 | 13.0±2.8 | 0.62 |
| Biological sex, n | |||
| Female | 16 | 20 | 0.87 |
| Male | 11 | 15 | |
| BMI z-score | 1.61±0.86 | 0.80±0.95 | 0.001 |
| Ethnicity, n | |||
| Hispanic | 11 | 20 | 0.28 |
| Non-Hispanic | 16 | 15 | |
| Race, n | |||
| White | 19 | 24 | 0.64 |
| Black | 1 | 3 | |
| Asian | 2 | 3 | |
| Native American | 0 | 1 | |
| Unknown | 5 | 4 | |
| CAH Form, n | |||
| Salt-wasting | 24 | – | – |
| Simple-virilizing | 3 | ||
| CAH medications | |||
| Glucocorticoid dose, mg/m2/day | 15.1±2.9 | – | – |
| Fludrocortisone dose, mg/day | 0.10±0.04 | ||
| CAH analytes | |||
| 17-OHP, ng/dL | 2,125 [736, 4,324] | – | – |
| nmol/L | 64.39 [22.3, 131.02] | ||
| Testosterone, ng/dL | 2 [0.7, 6.4] | ||
| nmol/L | 0.07 [0.02, 0.22] | ||
| Androstenedione, ng/dL | 75 [31, 94] | ||
| nmol/L | 2.62 [1.08, 3.28] | ||
| Plasma renin activity, ng/mL/h and µg/L/h | 3.46 [1.12, 5.41] | ||
| Highest newborn 17-OHP, ng/dL | 15,300 [7,600, 25400] | ||
| nmol/L | 463.59 [230.28, 769.62] | ||
Mean ± SD; median [IQR].